Blog
Prefilled Syringe Presentation of GSK’s SHINGRIX Receives Positive CHMP Opinion
On October 21, 2025, GSK announced that the European Medicine Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) adopted a positive opinion for the shingle vaccine SHINGRIX (recombinant zoster vaccine) in a prefilled syringe….
By: Goodwin